experimental group:Doxercalciferol injection for treatment

2 trials

Sponsors

Renji Hospital, Shanghai Tiaotong University School of Medicine, Jiangsu Province Hospital

Conditions

Secondary Hyperparathyroidism in patients with chonic kidney disease on dialysisSecondary hyperparathyroidism in hemodialysis patients

Phase 3

Clinical study on the treatment of secondary hyperparathyroidism in patients with maintenance hemodialysis by Doxercalciferol injection

Active, not recruitingChiCTR2100052077

Renji Hospital, Shanghai Tiaotong University School of MedicineSecondary hyperparathyroidism in hemodialysis patients

Start: 2021-11-01Updated: 2022-06-27

Unknown Phase

An Open-Label, Randomized, Single-arm, Multicenter Study to Assess the Safety and Efficacy of Doxercalciferol Injection in Patients With Chronic Kidney Disease With Secondary Hyperparathyroidism on Dialysis

Active, not recruitingChiCTR2300073196

Jiangsu Province HospitalSecondary Hyperparathyroidism in patients with chonic kidney disease on dialysis

Start: 2023-07-15Updated: 2023-07-10

Related Papers

Efficacy and safety of intermittent intravenous doxercalciferol in the treatment of secondary hyperparathyroidism in Chinese patients on maintenance hemodialysis: a phase II, open-label, prospective, multicenter study

Frontiers in Pharmacology2025-04-11